Inventiva
inventivapharma.com
Actively hiring
Cardiometabolic Therapeutics
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
Inventiva Reports Unaudited 2026 First-Half Financial Results and Provides Corporate Update
Read more
Report
Inventiva Reports Narrower H1 Loss; MASH Drug Readout Expected This Quarter
Inventiva (IVA) reported a first-half 2026 net loss of EUR69.5 million, narrowing from EUR175.9 million a year earlier, while revenue fell to EUR0.02 million from EUR4.
Read more
Report
Inventiva H1 Loss Drops
Inventiva (IVA) released Loss for first half of -EUR69.47 million The company's earnings came in at -EUR69.47 million, or -EUR0.25 per share. This compares with -EUR175.
Read more
Report
Inventiva publie ses résultats financiers non audités du premier semestre 2026 et fait le point sur ses activités
Trésorerie et équivalents de trésorerie à 166,1 millions d'euros et dépôts à court terme1 à 67,8...
Read more
Report
Inventiva announces completion of enrollment in the Phase 3 NATiV3 clinical trial of lanifibranor in patients with MASH and advanced fibrosis
Read more
Report
Inventiva announces the publication of the results from the investigator-initiated proof-of-concept clinical trial evaluating lanifibranor in patients with T2D and MASLD in the Journal of Hepatology
As previously reported 1, the study met the primary efficacy endpoint for the treatment with lanifibranor 800 mg demonstrating a 44% reduction of hepatic fat measured by proton magnetic resonance spectroscopy following 24 weeks of treatment in patients wi
Read more
Report
Inventiva announces the positive recommendation of the third DMC of the Phase III clinical trial with lanifibranor in patients with NASH
The DMC recommended to continue the clinical trial without modification of the protocol, based on the pre-planned review of safety data The safety assessment was based on the review of safety data from more than 500 patients, including patients that have
Read more
Report
Innovation In India- Challenges And Opportunities
The Global Innovation Index was released a few months ago and India was ranked 48th among 131 countries. The World Intellectual Property Organization ranked
Read more
Report
Show more news